Health News Roundup: Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot; Pfizer to invest more than $2.5 billion …
Health News Roundup: Merck could keep its patent edge by shifting Keytruda cancer drug to a simple shot; Pfizer to invest more than $2.5 billion …